Conflict of interest in the healthcare industry

There is a lack of empirical evidence to describe the impact of conflict of interest in the health care industry.[1]

Business interests influence the direction of cancer research and the adoption of new practices in therapy.[2]

University projects which receive industry funding are more likely to produce research outcomes which favor their funders.[3]

A 2017 systematic review by the Cochrane Collaboration found that pharmaceutical and medical device industry sponsored studies are more often favorable to the sponsor's product compared with studies with other sources of sponsorship.[4]

The trend toward treating clinical research as a business has coincided with a range of problems which are likely the result of business connections.[5]

Funders seek and court scientists to author papers and lend their person reputations to add credibility to research findings.[6]

The Physician Payments Sunshine Act of 2010 requires that financial relationships of physicians and teaching hospitals with manufacturers be reported and made publicly available via the Open Payments Program website.

Using this Open Payments database, it was found that about 64% of US-based physician-editors of highly-cited medical journals received industry-associated payments (i.e., payments from medical drug and device companies) during a period spanning August 1, 2013 to December 31, 2016.[7]

Medical journals have varying requirements what should be published and people who fail to follow them face few repercussions.[8]

• Rodwin, Marc A. (2011). Conflicts of Interest and the Future of Medicine: The United States, France, and Japan. Oxford University Press. ISBN 9780199792504. Retrieved 2015-05-14.
• Practice, Committee on Conflict of Interest in Medical Research, Education, and; Policy, Board on Health Sciences; Medicine, Institute of (2009-09-16). Conflict of Interest in Medical Research, Education, and Practice. National Academies Press. ISBN 9780309145442. Retrieved 2015-05-14.